Juva Life Inc (JUVAF)
0.0339
0.00 (0.00%)
USD |
OTCM |
May 10, 15:35
Juva Life Research and Development Expense (Quarterly): 0.0837M for March 31, 2023
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2023 | 0.0837M |
| September 30, 2022 | 0.0372M |
| June 30, 2022 | 0.0341M |
| March 31, 2022 | 0.0656M |
| September 30, 2021 | 0.1216M |
| Date | Value |
|---|---|
| June 30, 2021 | 0.0597M |
| March 31, 2021 | 0.00 |
| December 31, 2020 | |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
Jun 2020
0.1216M
Maximum
Sep 2021
0.0447M
Average
0.0372M
Median
Sep 2022
Research and Development Expense (Quarterly) Benchmarks
| Rimrock Gold Corp | -- |
| InMed Pharmaceuticals Inc | 0.6098M |
| Venus Concept Inc | 1.67M |
| CEN Biotech Inc | -- |
| Lucy Scientific Discovery Inc | -- |